Tardive Dyskinesia Latest Advances
Find the Latest Research About Tardive Dyskinesia
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3117 publications
Response to [Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia].
Journal: Psychiatry and clinical neurosciences
Published: May 30, 2026
Genetics of tardive dyskinesia: a review of progress over the past decade.
Journal: Pharmacogenomics
Published: May 18, 2026
Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia.
Journal: Psychiatry and clinical neurosciences
Published: May 09, 2026
Measuring What Matters: Further Validation for the Tardive Dyskinesia Impact Scale, a Novel Patient-Reported Outcome Measure in Valbenazine Clinical Trials.
Journal: The Journal of clinical psychiatry
Published: May 07, 2026
The Patient Perspective on Tardive Dyskinesia.
Journal: The Journal of clinical psychiatry
Published: May 07, 2026
Tardive Dystonia Described as Tardive Tremor.
Journal: Journal of general and family medicine
Published: April 16, 2026
Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.
Journal: Schizophrenia (Heidelberg, Germany)
Published: April 03, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.
Journal: The British journal of psychiatry : the journal of mental science
Published: March 25, 2026
SOM3355: a unique pharmacological profile combining VMAT1 inhibition, VMAT2-mediated dopamine modulation, and β1-adrenergic antagonism for the treatment of movement and neuropsychiatric disorders.
Journal: Frontiers in pharmacology
Published: March 06, 2026
Living with tardive dyskinesia: understanding the patient experience.
Journal: CNS spectrums
Published: March 02, 2026
Last Updated: 06/30/2026